Tuesday, December 03, 2019 8:02:17 PM
____
Andrew F Dorr -
April 21, 2017
F. Andrew Dorr, M.D., the Company’s previous interim chief medical officer, will transition his work to focus on the clinical development of the Company’s oncology programs.
https://seekingalpha.com/filing/3510273
______
Andrew F Dorr, who was not on research published reports of Peregrine re: biomarkers ...but does show up with Joe Shan, Steve King and Nikoletta Kallinteris with patent date filing below...dated
(Page 8 of 12 ...verified that MOS not met yet )
(54) METHODS FOR TREATING CANCER USING PS-TARGETING ANTIBODIES WITH IMMUNO -ONCOLOGY AGENTS
(71) Aplicant:
ONCOLOGIE,INC.,
WestNewton, MA (US)
(72) Inventors:
JosephS.Shan,Tustin,CA(US); NikoletaL.Kalinteris,Tustin,CA(US);
Min Tang,Tustin,CA (US);
F. Andrew Dorr,Tustin,CA (US)
(21) Apl.No.:15/943,304
(2)Filed: Apr.2,2018
https://patentimages.storage.googleapis.com/b4/e9/50/d138e8f8a7a2b2/US20180289771A1.pdf
________
Who knows, maybe S-Bio wants IP asset knowledge
S*BIO Pte Ltd
S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs.
Singapore, Central Region, Singapore
Categories
Biotechnology, Genetics, Life Science
Headquarters Regions
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Sub-Organization of
Logo of Chiron Corporation
Chiron Corporation
Founded Date
2000
Operating Status
Active
IPO Status
Private
S*Bio Pte Ltd. (Singapore), The principle activity of the company is the discovery and development of novel, proprietary small molecule anti-cancer drugs. This is done through an in-house discovery team located in Singapore and a clinical development team located in Singapore and Calfornia.
https://www.crunchbase.com/organization/s-bio-pte-ltd
_____
I wonder why Lana Gladstein was hired by Mark Bamforth new CDMO Arranta...maybe she advised Jeffrey Gladstein ( Merrill Lynch Wells Fargo) to buy big CDMO and maybe Christopher Sargent also of Merrill Lynch Wells Fargo buys big CDMO (Chris had to leave Wells Fargo for a reason and split off ....and started the buying already for some
As for Andrew F Dorr....he holds key Biomarker info and knows PS Targeting is huge ..so I wonder why James Allison and crew over at "Imaginab" required PS Targeting input from Andrew F Dorr ...as they seeked him out AFTER the patent and Biomarkers etc
Merck or another....should just open the vault
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM